相关实验视频

Updated: Jun 7, 2025

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent

Published on: September 3, 2013

作为血管和脏成像的高性能MRI对比剂的单点突变兰莫杜林

Yuxia Liu^1,2, Duyang Gao^3,4, Yuanyuan He^5,6

¹Department of Chemistry, National University of Singapore, Singapore, Singapore.

Nature communications

|November 13, 2024

概括

一种新的蛋白质对比剂,LanND-Gd,提供增强的磁共振成像 (MRI),具有卓越的图像质量和生物相容性. 这种先进的药物可以提高诊断精度和患者监测,同时最大限度地降低毒性风险.

科学领域:

生物化学生物化学
生物材料科学生物材料科学
医疗成像医学成像

背景情况:

磁共振成像 (MRI) 的对比剂提高了诊断准确度.
目前的药物面临着局限性:短的成像窗口,低特异性,毒性和低于最佳的增强.
这些局限性影响图像分辨率和长期患者监测.

研究的目的:

开发一种基于蛋白质的新型MRI对比剂,其性能和安全性得到改善.
设计一种基于兰莫杜林的药物,具有增强的加多结合能力.
在临床前模型中评估工程制剂 (LanND-Gd) 的疗效和安全性.

主要方法:

具有单点突变 (N108D) 的工程兰莫杜林蛋白对于最大的加多 (Gd3+) 结合.
装载有Gd3+离子的工程蛋白质,以创建LanND-Gd复合体.
在雄性小鼠中评估LanND-Gd对清除,放松性,保留和成像性能 (全身,大脑血管系统).
在男性缺血小鼠模型中评估LanND-Gd,以监测功能障碍和毒性.

主要成果:

与商业药物相比,LanND-Gd表现出高效的清和长时间的保留.
实现了高放松性,使结构和血管系统的高性能可视化在100微米以下的分辨率.
在缺血模型中改善功能障碍的监测.
将神经毒性和免疫原反应的风险降至最低.

结论:

兰德-Gd是一种优质的基于蛋白质的MRI对比剂.
提供增强的图像质量,提高生物相容性和扩展的成像功能.
显示了推进MRI诊断和改善患者治疗结果的巨大潜力.

更多相关视频

Preparation, Purification, and Characterization of Lanthanide Complexes for Use as Contrast Agents for Magnetic Resonance Imaging

Preparation, Purification, and Characterization of Lanthanide Complexes for Use as Contrast Agents for Magnetic Resonance Imaging

Published on: July 21, 2011

Human In Vitro Suppression as Screening Tool for the Recognition of an Early State of Immune Imbalance

Human In Vitro Suppression as Screening Tool for the Recognition of an Early State of Immune Imbalance

Published on: July 22, 2011

相关概念视频

Magnetic Resonance Imaging

Magnetic Resonance Imaging

Magnetic resonance imaging (MRI) is a noninvasive medical imaging technique based on a phenomenon of nuclear physics discovered in the 1930s, in which matter exposed to magnetic fields and radio waves was found to emit radio signals. In 1970, a physician and researcher named Raymond Damadian noticed that malignant (cancerous) tissue gave off different signals than normal body tissue. He applied for a patent for the first MRI scanning device in clinical use by the early 1980s. The early MRI...

Imaging Studies for Cardiovascular System IV: CMRI

Imaging Studies for Cardiovascular System IV: CMRI

Cardiovascular magnetic resonance imaging, or CMRI, is a non-invasive diagnostic test that employs a magnetic field and radiofrequency waves to create precise images of the heart and arteries. It provides comprehensive information about cardiac anatomy, function, perfusion, and tissue characterization without ionizing radiation.IndicationsCMRI diagnoses various heart conditions, including tissue damage from heart attacks, ischemic heart disease, myocarditis, aortic issues (tears, aneurysms,...